MicroRNA-92b promotes hepatocellular carcinoma progression by targeting Smad7 and is mediated by long non-coding RNA XIST

Cell Death and Disease

Volumn 7, Issue 4, 2016, Pages

  Zhuang, L K ^a   Yang, Y T ^a   Ma, X ^a   Han, B ^a   Wang, Z S ^a   Zhao, Q Y ^a   Wu, L Q ^a   Qu, Z Q ^a  

^a QINGDAO UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LONG UNTRANSLATED RNA; MICRORNA; MICRORNA 92B; SMAD7 PROTEIN; UNCLASSIFIED DRUG; ANTISENSE OLIGONUCLEOTIDE; BETA CATENIN; TUMOR MARKER; VIMENTIN; XIST NON-CODING RNA;

ADULT; ARTICLE; CANCER GROWTH; CANCER PATIENT; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; GENE INTERACTION; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; METASTASIS; MIDDLE AGED; PRIORITY JOURNAL; SEX DIFFERENCE; TUMOR INVASION; UPREGULATION; X INACTIVE SPECIFIC TRANSCRIPT GENE; AGED; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; BLOOD; CELL MOTION; CHEMISTRY; DISEASE COURSE; GENETICS; LIVER TUMOR; LUNG TUMOR; METABOLISM; MOUSE; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PATHOLOGY; SECONDARY; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; TUMOR CELL LINE; XENOGRAFT;

AGED; ANIMALS; BASE SEQUENCE; BETA CATENIN; BIOMARKERS, TUMOR; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DISEASE PROGRESSION; FEMALE; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; MIDDLE AGED; OLIGONUCLEOTIDES, ANTISENSE; RNA, LONG NONCODING; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; SMAD7 PROTEIN; TRANSPLANTATION, HETEROLOGOUS; VIMENTIN;

EID: 84978896354     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2016.100     Document Type: Article

References (35)

1. Villanueva A, Hoshida Y, Toffanin S, Lachenmayer A, Alsinet C, Savic R et al. New strategies in hepatocellular carcinoma: genomic prognostic markers. Clin Cancer Res 2010; 16: 4688-4694.
2. Fan ST, Mau Lo C, Poon RT, Yeung C, Leung Liu C, Yuen WK et al. Continuous improvement of survival outcomes of resection of hepatocellular carcinoma: A 20-year experience. Ann Surg 2011; 253: 745-758.
3. Cho WC. MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Int J Biochem Cell Biol 2010; 42: 1273-1281.
4. Khoury S, Tran N. Circulating microRNAs: potential biomarkers for common malignancies. Biomarkers Med 2015; 9: 131-151.
5. Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 2010; 11: 597-610.
6. Zhuang LK, Xu GP, Pan XR, Lou YJ, Zou QP, Xia D et al. MicroRNA-181a-mediated downregulation of AC9 protein decreases intracellular cAMP level and inhibits ATRA-induced APL cell differentiation. Cell Death Dis 2014; 5: e1161.
7. Gao Y, Meng H, Liu S, Hu J, Zhang Y, Jiao T et al. LncRNA-HOST2 regulates cell biological behaviors in epithelial ovarian cancer through a mechanism involving microRNA let-7b. Hum Mol Genet 2015; 24: 841-852.
8. Fang F, Chang RM, Yu L, Lei X, Xiao S, Yang H et al. MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma. J Hepatol 2015; 63: 874-885.
9. Ma MZ, Chu BF, Zhang Y, Weng MZ, Qin YY, Gong W et al. Long non-coding RNA CCAT1 promotes gallbladder cancer development via negative modulation of miRNA-218-5p. Cell Death Dis 2015; 6: e1583.
10. Cui M, Xiao Z, Wang Y, Zheng M, Song T, Cai X et al. Long noncoding RNA HULC modulates abnormal lipid metabolism in hepatoma cells through an miR-9-mediated RXRA signaling pathway. Cancer Res 2015; 75: 846-857.
11. Yao Y, Ma J, Xue Y, Wang P, Li Z, Liu J et al. Knockdown of long non-coding RNA XIST exerts tumor-suppressive functions in human glioblastoma stem cells by up-regulating miR-152. Cancer Lett 2015; 359: 75-86.
12. Lu FI, Sun YH, Wei CY, Thisse C, Thisse B. Tissue-specific derepression of TCF/LEF controls the activity of the Wnt/beta-catenin pathway. Nat Commun 2014; 5: 5368.
13. Millar SE. Smad7: licensed to kill beta-catenin. Dev Cell 2006; 11: 274-276.
14. Kan H, Guo W, Huang Y, Liu D. MicroRNA-520 g induces epithelial-mesenchymal transition and promotes metastasis of hepatocellular carcinoma by targeting SMAD7. FEBS Lett 2015; 589: 102-109.
15. Huang JL, Zheng L, Hu YW, Wang Q. Characteristics of long non-coding RNA and its relation to hepatocellular carcinoma. Carcinogenesis 2014; 35: 507-514.
16. Mizuguchi Y, Takizawa T, Yoshida H, Uchida E. Dysregulated microRNAs in progression of hepatocellular carcinoma: A systematic review. Hepatol Res 2015 (e-pub ahead of print).
17. Giordano S, Columbano A. MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma? Hepatology 2013; 57: 840-847.
18. Iqbal J, Shen Y, Huang X, Liu Y, Wake L, Liu C et al. Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma. Blood 2015; 125: 1137-1145.
19. Liu W, Ling S, Sun W, Liu T, Li Y, Zhong G et al. Circulating microRNAs correlated with the level of coronary artery calcification in symptomatic patients. Scientific Rep 2015; 5: 16099.
20. Patel M, Verma A, Aslam I, Pringle H, Singh B. Novel plasma microRNA biomarkers for the identification of colitis-associated carcinoma. Lancet 2015; 385(Suppl 1): S78.
21. Wu ZB, Cai L, Lin SJ, Lu JL, Yao Y, Zhou LF. The miR-92b functions as a potential oncogene by targeting on Smad3 in glioblastomas. Brain Res 2013; 1529: 16-25.
22. Li Y, Li L, Guan Y, Liu X, Meng Q, Guo Q. MiR-92b regulates the cell growth, cisplatin chemosensitivity of A549 non small cell lung cancer cell line and target PTEN. Biochem Biophys Res Commun 2013; 440: 604-610.
23. Wang K, Wang X, Zou J, Zhang A, Wan Y, Pu P et al. miR-92b controls glioma proliferation and invasion through regulating Wnt/beta-catenin signaling via Nemo-like kinase. Neurooncology 2013; 15: 578-588.
24. Li Q, Shen K, Zhao Y, Ma C, Liu J, Ma J. MiR-92b inhibitor promoted glioma cell apoptosis via targeting DKK3 and blocking the Wnt/beta-catenin signaling pathway. J Transl Med 2013; 11: 302.
25. Pei Y, Kano J, Iijima T, Morishita Y, Inadome Y, Noguchi M. Overexpression of Dickkopf 3 in hepatoblastomas and hepatocellular carcinomas. Virchows Archiv 2009; 454: 639-646.
26. Chen HW, Qiao HY, Li HC, Li ZF, Zhang HJ, Pei L et al. Prognostic significance of Nemo-like kinase expression in patients with hepatocellular carcinoma. Tumour Biol 2015; 36: 8447-8453.
27. Shen Q, Bae HJ, Eun JW, Kim HS, Park SJ, Shin WC et al. MiR-101 functions as a tumor suppressor by directly targeting nemo-like kinase in liver cancer. Cancer Lett 2014; 344: 204-211.
28. Kawakami T, Okamoto K, Sugihara H, Hattori T, Reeve AE, Ogawa O et al. The roles of supernumerical X chromosomes and XIST expression in testicular germ cell tumors. J Urol 2003; 169: 1546-1552.
29. Ren C, Li X, Wang T, Wang G, Zhao C, Liang T et al. Functions and mechanisms of long noncoding RNAs in ovarian cancer. Int J Gynecol 2015; 25: 566-569.
30. Yildirim E, Kirby JE, Brown DE, Mercier FE, Sadreyev RI, Scadden DT et al. Xist RNA is a potent suppressor of hematologic cancer in mice. Cell 2013; 152: 727-742.
31. Lo HC, Wu SC, Huang HC, Yeh CC, Huang JC, Hsieh CH. Laparoscopic simple closure alone is adequate for low risk patients with perforated peptic ulcer. World J Surg 2011; 35: 1873-1878.
32. Guy J, Peters MG. Liver disease in women: The influence of gender on epidemiology, natural history, and patient outcomes. Gastroenterol Hepatol 2013; 9: 633-639.
33. Ruggieri A, Barbati C, Malorni W. Cellular and molecular mechanisms involved in hepatocellular carcinoma gender disparity. Int J Cancer 2010; 127: 499-504.
34. Zhu H, Elyar J, Foss R, Hemming A, Hall E, Lecluyse EL et al. Primary human hepatocyte culture for HCV study. Methods Mol Biol 2009; 510: 373-382.
35. Chang Y, Liu C, Yang J, Liu G, Feng F, Tang J et al. MiR-20a triggers metastasis of gallbladder carcinoma. J Hepatol 2013; 59: 518-527.